Activity

The U.S. FDA Has Approved The First Long-Acting Monthly 2-Shot Drug Combo That Can Replace Daily HIV Pills. The Combo, Called Cabenuva, Comprises Rilpivirine, Sold As Edurant By Johnson & Johnson, And A New Drug, Cabotegravir, From ViiV Healthcare. The Combo Are Given As Separate Shots Once A Month. 2 Months Dosing Is Also Being Tested.

FDA approves 1st long-acting HIV drug combo, monthly shots – Los Angeles Times

https://www.latimes.com/world-nation/story/2021-01-22/fda-approves-1st-long-acting-hiv-drug-combo-monthly-shots

U.S. regulators have approved the first long-acting drug combination for HIV, monthly shots that can replace daily pills.